Matthew C. Exline

Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network — United States, March–June 2020

Mark W. Tenforde, Sara Kim, Christopher J. Lindsell et al. · MMWR Morbidity and Mortality Weekly Report · 2020 · 1.4K citations · Full text

Prolonged Symptom Duration, Population Health Sciences, Covid-19 Epidemiology +19

Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity

Mark W. Tenforde, Wesley H. Self, Katherine Adams et al. · JAMA · 2021 · 671 citations · Full text

Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study

Adam S. Lauring, Mark W. Tenforde, James D. Chappell et al. · BMJ · 2022 · 666 citations · Full text

Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial

Michael A. Matthay, Carolyn S. Calfee, Hanjing Zhuo et al. · The Lancet Respiratory Medicine · 2018 · 612 citations · Full text

Acute Lung Injury, Respiratory Distress Syndrome (Pulmonary Critical Care), Randomised Phase 2A +9

Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness

Timothy D. Girard, Matthew C. Exline, Shannon S. Carson et al. · New England Journal of Medicine · 2018 · 548 citations · Full text